Pharma Co. Tells CIT Its Drugs Are Made In U.S., Not India

Law360 (March 7, 2018, 10:07 PM EST) -- A New Jersey-based pharmaceutical company that sells a generic version of the cholesterol drug Crestor to the federal government asked Tuesday that the Court of International Trade determine that the drug is manufactured in the U.S. and not India, as U.S. Customs and Border Protection attests.

Acetris Health LLC contends that because its Rosuvastatin Calcium tablets are “indisputably” manufactured in the U.S., they qualify as U.S.-made end products under the Federal Acquisition Regulation, the set of rules used by the federal government for acquiring products from...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.